A warning on the bottle that is on nothing else

Exhibit 01

The sentence that is on the bottle

Here it is, word for word, from the left panel of the supplied label artwork. It sits under its own heading, separate from the ordinary caution.

Count what that sentence does. It names a mechanism, blood pressure. It names four groups of people the product is not for: hypertension, heart disease, liver disorders, kidney disorders. And it names a pattern of use, prolonged periods without medical supervision, on a product sold in packs that run 60, 90 and 180 days at the printed serving.

The label carries an ordinary caution as well, doing a different job: Do not exceed recommended dose. Pregnant or nursing mothers, children under the age of 18 and individuals with a known medical condition should consult a physician before using this or any dietary supplement. The licorice warning is the specific one. It names conditions, and somebody chose to print it.

Exhibit 02

What NCCIH records about glycyrrhizin

The warning is not the manufacturer’s private opinion. The federal centre that publishes on herbal products says the same at more length, and one of its sentences is why this post exists.

The second of those changes how the first reads. A reader who meets large amounts or long term can reasonably conclude that a small amount is fine, and NCCIH says that for some people it is not. Its general advice is the advice this site gives about every line on this panel: “If you take any type of medicine, talk with your health care provider before using licorice or other herbal products; some herbs and medicines interact in harmful ways.”

Exhibit 03

The size of the concern is not published

Here is where the label stops being helpful. It tells you the warning applies. It does not tell you how much of the thing it is warning about is in a capsule.

Two figures are missing and they are the two that would settle it. How much licorice a serving contains: Not published. How much glycyrrhizin that licorice carries: Not published, because the licorice line carries no standardisation. Only two of the twelve blend members carry one at all, the guggul at 10% guggulsterones and the banaba at 1% corosolic acid.

What can be done is a bound. 21 CFR 101.36(c)(2) requires the members of a proprietary blend to be declared in descending order of predominance by weight. If the order is descending and the whole blend is 82 mg, the member in position n cannot weigh more than 82/n milligrams. Licorice is listed first, so its ceiling is the whole 82 mg. Every figure of that kind is a maximum. It is never the amount in the capsule, and the real weight may be a small fraction of it. And being first means the bound is the blend total restated: it rules nothing out. The first position is where the arithmetic says least, which is an unfortunate place for the warned-about ingredient to sit.

So the honest summary is three lines. The manufacturer thought this worth a printed warning. The federal source agrees it can matter, at small amounts, for particular people. And the number that would let you weigh it is not published. The ingredients page takes the other eleven members through the same exercise.

Exhibit 04

Absent from every piece of marketing in the folder

Three seller-made panels came with this stock. Licorice is named on none of them, and neither is the warning.

The INSIDE GLUCOTIDE panel is subtitled SIX VITAL NUTRIENTS and shows six cards. The 82 mg blend does not appear on it at all, so neither does the ingredient the bottle prints a warning about.

The HOW GLUCOTIDE WORKS panel is the dosing sentence cut into four steps. The WHAT GLUCOTIDE SUPPORTS panel is four asterisked lines, all four of which also appear on the bottle. Neither names an ingredient with a caution attached to it.

That is the gap this post exists to close. A reader who bought from those graphics would meet the warning for the first time when the bottle arrived, and the people it names are the people who would have wanted it first.

Exhibit 05

Read the warnings panel before the ingredient panel

The general lesson is worth more than this bottle. A manufacturer prints a warning reluctantly and a seal enthusiastically, and that asymmetry tells you which one to read first.

Think what it takes for each to reach a label. A seal costs artwork, and it can be there because somebody liked how it looked: eight seal marks came with this stock, and no certifying body, certificate number or audit date was supplied for any of them. A printed warning subtracts from the sales pitch. It tells a proportion of the readers not to buy, and it is on the package anyway.

So the reading order that follows is not the one the package is designed for:

1. Find the warnings panel first

   Not the seals, not the front. It is the only sentence on this bottle naming a medical condition.

2. Ask what ingredient it is about

   Here it names licorice, which sits in the proprietary blend rather than among the seven nutrients with weights.

3. Ask whether the amount is published

   If it is not, the warning can be read but not weighed. Saying so beats estimating.

4. Then read the seals

   Artwork until a certifying body, a number and a date arrive. The testing and quality page covers what was supplied here.

On this label that order pays immediately. The warning names a mechanism and four conditions. The panel then puts the ingredient it names inside a blend, first in the order, with no weight. The label-reading guide runs the same method as a procedure, and the label page is where the label is transcribed.